In a recent report, inhibition of ataxia telangiectasia and Rad3-related checkpoint kinase 1 (ATR-Chk1) was shown to enhance oncolytic toxicity of adenovirus in ovarian cancer by using the small molecule inhibitor UCN-0134. This evidence concerns the gene ATR and ovarian cancer.